Research
- Research
- Biosimilars
- Drug Abuse Prevention
- Drug Adherence Programs
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Employers, Unions, & Insurers
- FEHB Program
- Formulary Design
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Health Insurance Marketplace (ACA)
- Home Delivery of Drugs
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- REMS Management
- Specialty Benefit Design
- Specialty Pharmacies
- Specialty Pharmacy Networks
- TRICARE
The Unintended Consequences of the DOL PBM Transparency Rule: An Ode to the Little Guy (and Gal)
September 03, 2026
By Amanda Frost, PhD Vice President, Research, PCMA The law of unintended consequences, when an action produces unexpected effects outside...
Want to Understand the Prescription Drug Supply Chain? Start at the Wholesalers
August 25, 2026
By Amanda Frost, PhD Vice President, Research, PCMA Last year, the U.S. spent $1.363 trillion on prescription drugs, and every...
How the Future of GLP-1 Affordability Depends on Competition
July 29, 2026
By Amanda Frost, PhD Vice President, Research, PCMA There is no shortage of opinions these days about GLP-1 prescription drugs:...
From Flashy Ads to Expensive Drugs: 5 Things You Need to Know About Misleading Drug Advertisements
July 27, 2026
By Amanda Frost, PhD Vice President, Research, PCMA I don’t watch much television these days, but when I do, I can be assured of...
What Would You Do to Protect $50 Billion a Year?
July 22, 2026
By Amanda Frost, PhD Vice President, Research, PCMA Did you know: the original patent for semaglutide – better known as...
Missing from the VI Debate: Data That Shows It’s A Problem
June 03, 2026
By Amanda Frost, PhD Vice President, Research, PCMA Concerns about high health care costs are prevalent and appropriate, but can be often focused on the wrong place. Vertical integration (VI) is one area that is receiving attention from state and federal policymakers, with a...

Innovation That Puts Patients First
July 16, 2025
Every year, like clockwork, drug prices go up. For many patients, those increases aren’t just numbers on a chart; they’re...
The Return on Investment (ROI) on PBM Services
March 04, 2025
Pharmacy Benefit Managers (PBMs) help reduce prescription drug costs for 289 million Americans. Read More...
Increased Costs Associated With Proposed State Legislation Impacting PBM Tools
March 04, 2025
Visante was commissioned by the Pharmaceutical Care Management Association (PCMA) to estimate the potential cost impact of four types of...
Pharmacy Benefit Managers (PBMs): Generating Savings for Plan Sponsors and Consumers
March 04, 2025
Pharmacy Benefit Managers (PBMs) now implement prescription drug benefits for some 289 million Americans who have health insurance from a...

Dispensing Fee Mandates Increase Drug Spending; Here Is the Data
January 22, 2025
West Virginia dispensing fee law is a warning of the effects of mandated reimbursements....

December 04, 2023
Pharmacy benefit companies negotiate rebates from drug companies, which they pass to health plan sponsors. Health plan sponsors then use...
